(Q40636040)

22 September 2017

Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive (English)

1 reference

22 September 2017

1

Andrew J Dodgshun

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jordan Hansford

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

4

Michael J Sullivan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

James E Elder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

17 August 2015

1 reference

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

4190-4196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26280460%20AND%20SRC:MED&resulttype=core&format=json

Optic pathway gliomas: a review.

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Retrospective analysis of patients attending a neurofibromatosis type 1 clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

The value of radiation therapy in the management of glioma of the optic nerves and chiasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Natural history and outcome of optic pathway gliomas in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Vision specific quality of life in children with optic pathway gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Visual improvement despite radiologically stable disease after treatment with carboplatin in children with progressive low-grade optic/thalamic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Visual acuity of children treated with chemotherapy for optic pathway gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Functional outcome measures for NF1-associated optic pathway glioma clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.29649